| Primary |
| Pruritus |
21.9% |
| Dermatitis Atopic |
18.8% |
| Dermatitis |
6.3% |
| Laser Therapy |
6.3% |
| Skin Irritation |
6.3% |
| Blood Cholesterol Abnormal |
3.1% |
| Blood Pressure Increased |
3.1% |
| Burning Sensation |
3.1% |
| Chronic Obstructive Pulmonary Disease |
3.1% |
| Dermatitis Contact |
3.1% |
| Erythema |
3.1% |
| Excoriation |
3.1% |
| Inflammation |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Rash |
3.1% |
| Rash Erythematous |
3.1% |
| Superinfection |
3.1% |
| Thermal Burn |
3.1% |
|
| Application Site Pain |
11.8% |
| Product Quality Issue |
11.8% |
| Application Site Pruritus |
5.9% |
| Drug Ineffective |
5.9% |
| Eczema |
5.9% |
| Off Label Use |
5.9% |
| Pain Of Skin |
5.9% |
| Product Substitution Issue |
5.9% |
| Pruritus |
5.9% |
| Skin Hypopigmentation |
5.9% |
| Therapeutic Response Decreased |
5.9% |
| Unevaluable Event |
5.9% |
| Weight Decreased |
5.9% |
| Wrong Drug Administered |
5.9% |
| Wrong Patient Received Medication |
5.9% |
|
| Secondary |
| Product Used For Unknown Indication |
41.9% |
| Eczema |
18.6% |
| Dermatitis Atopic |
11.6% |
| Eczema Infantile |
5.2% |
| Pruritus |
5.2% |
| Psoriasis |
2.9% |
| Dry Skin |
2.3% |
| Dyslipidaemia |
2.3% |
| Skin Disorder |
1.7% |
| Drug Use For Unknown Indication |
1.2% |
| Skin Irritation |
1.2% |
| T-cell Lymphoma |
1.2% |
| Asthma |
0.6% |
| Blood Cholesterol Abnormal |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Blood Pressure Increased |
0.6% |
| Burning Sensation |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Erythema |
0.6% |
| Excoriation |
0.6% |
|
| Osteonecrosis |
19.4% |
| Cushing's Syndrome |
9.7% |
| Off Label Use |
9.7% |
| Medication Error |
6.5% |
| Pregnancy |
6.5% |
| Application Site Pain |
3.2% |
| Blepharitis |
3.2% |
| Breast Swelling |
3.2% |
| Drug Ineffective |
3.2% |
| Feeling Abnormal |
3.2% |
| Growth Retardation |
3.2% |
| Haemorrhage |
3.2% |
| Hypersensitivity |
3.2% |
| Intentional Drug Misuse |
3.2% |
| Lacrimation Increased |
3.2% |
| Maternal Drugs Affecting Foetus |
3.2% |
| Pruritus |
3.2% |
| Rash Erythematous |
3.2% |
| Rash Macular |
3.2% |
| Skin Exfoliation |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.6% |
| Psoriasis |
10.3% |
| Hypertension |
9.6% |
| Multiple Myeloma |
5.7% |
| Eczema |
4.1% |
| Prophylaxis |
3.9% |
| Rheumatoid Arthritis |
3.7% |
| Diarrhoea |
3.4% |
| Colitis Ulcerative |
3.2% |
| Psoriatic Arthropathy |
2.8% |
| Pain |
2.7% |
| Dermatitis Atopic |
2.5% |
| Anxiety |
2.4% |
| Asthma |
2.4% |
| Blood Cholesterol |
2.3% |
| Blood Pressure |
2.3% |
| Osteoarthritis |
2.1% |
| Arthralgia |
2.0% |
| Fluid Retention |
2.0% |
| Rash |
2.0% |
|
| Weight Decreased |
13.2% |
| X-ray Abnormal |
9.2% |
| Vomiting |
8.6% |
| Pyrexia |
7.2% |
| Pulmonary Embolism |
6.6% |
| Syncope |
5.9% |
| Tendonitis |
4.6% |
| Ventricular Tachycardia |
4.6% |
| Wound Infection |
4.6% |
| Drug Ineffective |
3.9% |
| Oedema Peripheral |
3.9% |
| Pancreatitis |
3.9% |
| Squamous Cell Carcinoma |
3.9% |
| Dizziness |
3.3% |
| Psoriasis |
3.3% |
| Anxiety |
2.6% |
| Crohn's Disease |
2.6% |
| Nausea |
2.6% |
| Pain |
2.6% |
| Platelet Count Decreased |
2.6% |
|
